Zimmer Biomet Receives 510(k) Clearance For ROSA Partial Knee System
The ROSA Partial Knee is part of Zimmer Biomet’s connected intelligence suite, which provides key analytics to health providers throughout a patient’s care continuum.
You may also be interested in...
J&J, Smith & Nephew, Stryker, Zimmer Biomet and other companies in the orthopedic and spine surgery space have welcomed a recent rebound in orthopedic device demand, but the volume of elective knee surgeries is still behind its pre-pandemic level.
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Minute Insight: Sema4 To Acquire Genomics Company GeneDx For $623M To Strengthen Clinical Data Platform
Genetic testing company Sema4 announced plans to buy GeneDx to strengthen Sema4’s health intelligence and genomic screening offers. The combined company is expected to generate $350m in pro forma 2022 revenue.